Author, Subjects, Keywords

Cited Author

 
 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Steroid Withdrawal or Avoidance in Renal Transplant Recipients

Chang, S.H., and Tan, S.Y., (2006) Steroid Withdrawal or Avoidance in Renal Transplant Recipients. Journal of the University of Malaya Medical Centre (JUMMEC), 9 (1). pp. 2-6. ISSN 1823-7339

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
110Kb

Official URL: http://jummec.um.edu.my

Affiliations

University of Malaya Medical Centre. Department of Medicine
Harvard Medical School

Abstract

ABSTRACT: Steroids remain an important component of maintenance immunosuppression after renal transplantation. Their anti-inflammatory action is partly due to the sequestration of CD4+ lymphocytes in the reticuloendothelial system. Steroids bind to intracellular receptors and the resulting steroid-receptor complex alters the transcription of cytokines by binding to glucocorticoid response elements on DNA. Transcription factors whose actions are altered by glucocorticoids include activating protein-1 (AP-1) and nuclear factor-B (NF-B). The main cytokines whose production by antigen-presenting cells is inhibited by steroids are interleukin-1 (IL-1), required for helper T-cell activation, and IL-6, required for B-cell activation. Other pro-inflammatory cytokines such as interferon gamma and tumour necrosis factor are also inhibited. This multiplicity of immunosuppressive actions is not fully replicated by other immunosuppressants. However, there are concerns about the long-term side effects of steroids. This review will examine the attempts at steroid withdrawal or steroid avoidance in renal transplant patients.

Item Type:Journal
Keywords:steroid withdrawal, renal transplantation,immunosuppressants
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:6366

1. Hricik DE. Steroid-free immunosuppression in kidney transplantation: An editorial review. Am J Transplant 2002; 2: 19-24.

2. United States Renal Data System. USRDS 1998 Annual Data Report.The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease,Bethesda, MD, 1997.

3. Veenstra DL, Best JH, Hornberger J, Sullivan SD, et al. The incidence and long-term cost of steroid-related side-effects after renal transplantation.Am J Kidney Dis1999; 33: 829-839.

4. Canadian Multicentre Trial Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 1983; 309: 809-815.

5. Canadian Multicentre Trial Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years. N Engl J Med 198; 314: 1219-1225.

6. European Multicentre Trial Group. Cyclosporine in cadaveric renal transplantation: one-year follow-up of a multicentre trial. Lancet 1983; 2: 986-989.

7. Schulak JA, Mayes JT, Moritz CE, et al. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients. Transplantaion 1990; 49: 327-332.

8. Kasiske BL, Chakkera HA, Louis TA, et al.A meta-analysis of immunosuppression withdrawal trials in renal transplantation.J Am Soc Nephrol 2000; 11: 1910-1917.

9. Ratcliffe PJ, Dudley CRK, Higgins RM, et al. Randomized controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996; 348: 643-648.

10. The Canadian Multicentre Transplant Study Group. Low dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. Can Med Assoc J 1992; 147: 645-656.

11. Sandrini S, Rizzo G,Valente U, et al. Basiliximab facilitates steroid withdrawal after renal transplantation: Results of an Italian multicentre, placebo-controlled study (SWISSstudy) (abstract).Am J Transplant 2002; 2 (S3): 172.

12. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and steroids for prevention of acute rejection. Lancet 1995; 345: 1321-1325.

13. US Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225-232.

14. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mucophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 1: 1029-1037.

15. The Steroid Dosing Study Group. Double-blind comparison of two corticosteroid regimen plus mycophenolate mofetil and cyclosporine for the prevention of acute renal allograft rejection.Transplantation 2000; 70:1352-1359.

16. Steroid Withdrawal Study Group. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil – A prospective randomized study.Transplantation 1999; 68: 1865-1874.

17, Francos GC, Frankel CJ, Dunn SR, et al. Double-blind, placebo-controlled, three year study of steroid withdrawal using a Neoral and mycophenolate mofetil (MMF)-based immunosuppressive regimen in primary renal transplant recipients (abstract). Am J Transplant;2(S3): 172.

18. Budde K, Fritsche L, Geissler S, et al. Steroid withdrawal in long-term cyclosporine A treated patients using mycophenolate mofetil: A prospective randomized pilot study. Transplant Proc 2001; 33: 3250-3252.

19. Boletis JN, Konstadinidou I, Chelioti H, et al. Successful withdrawal of steroids after renal transplantation. Transplant Proc 2001; 33: 1231-1233.

20. Pirsch JD, Miller J, Deierhoi MH, et al. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997;63: 977-983.

21. European Tacrolimus Multicenter Renal Study Group. Multicentre randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus

Multicenter Renal Study Group. Transplantation 1997;64: 436-443.

22. European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomized multicentre study.Lancet 2002; 359: 741-46.

23. Vincenti F, Jensik SC,Filo RS, et al. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 2002; 73: 1370.

24. Chakrabarti P, Wong HY, Toyofuku A, et al. Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc 2001. 33: 1235-1236.

25. Critterio F, Rigotti P, Scata MC, et al. Steroid withdrawal in renal transplant patients immunosuppressed with tacrolimus (abstract).Am J Transplant 2002; 2 (S3): 172.

26. Smiley ST, Csizmadia V, Gao W, et al. Differential effects of cyclosporine A, methylprednisolone, mycophenolate mofetil and rapamycin on CD154 induction and requirement for NF-B: implications for tolerance. Transplantation

2000; 70: 415-421.

27. Birkeland SA. Steroid-free immunosuppression in renal transplantation.Transplantation 2001; 71: 1089-1090.

28. Calne R, Moffatt SD, Friend PJ, et al. Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.Transplantation 1999; 68: 1613-1616.

29. Kaufman B, Leventhal JR, Fryer JP, et al. Kidney transplantation without prednisone (abstract) Transplantation 2000; 69 (supp) S133.

30. Cole E, Landsberg D, Russell D, et al. A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients.Transplantation 2001; 72: 845-850.

31. Zaltzman J, Cole E, Halloran P, Russell D, et al. Long-term follow-up of a steroid-free renal transplant cohort (abstract).Am J Transplant 2002; 2 (S3): 172.

32. van Riemsdijk I, Termeulen RG, Christiaans MH, et al. Anti-CD25 prophylaxis allows steroid-free renal transplantation in tacrolimus-based immunosuppression(abstract).Am J Transplant 2 (S3): 171.

33. Vincenti F, Monaco A, Grinyo J, et al. Rapid steroid withdrawal versus standard steroid treatment in patients treated with Simulect, Neoral, and Cellcept for the prevention of acute rejection in renal transplantation: A

multicentre, randomized trial (abstract).Transplantation 69 (supp) S133.

34. Kumar MSA, Fa K, Fyfe B, et al. Steroid avoidance in kidney transplant recipients treated with Simulect, Neoral and Cellcept – A randomized prospective controlled clinical trial (abstract). Am J Transplant 2002;2(S3): 393.

35. Mahalati K, Kahan BD. A Pilot study of steroid withdrawal from kidney transplant recipients on sirolimuscyclosporine A combination therapy. ransplant Proc 2001; 33: 3232-3233.

36. Sivaraman P, Nussbaumer G, et al. Lack of long-term benefits of steroid withdrawal in renal transplant recipients. Am J Kidney Dis 2001; 37: 1162-1169.

Repository Staff Only: item control page
 
 
 
 
 
 
© Copyright 2007 MyAIS Faculty of Computer Science and Information Technology, University of Malaya – All Rights Reserved. Malaysian Abstracting and Indexing System is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.